Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
05/2003
05/21/2003EP1311499A2 Bicyclic compounds as h3 receptor ligands
05/21/2003EP1311487A1 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings
05/21/2003EP1311482A2 Non-imidazole aryloxypiperidines as h3 receptor ligands
05/21/2003EP1311268A1 Imidazopyridine and imidazopyrimidine antiviral agents
05/21/2003EP1283711A4 Peptide deformylase inhibitors
05/21/2003EP1173439B1 Haloalkoxy imidazonaphthyridines
05/21/2003EP1147114B1 Novel aralkyl amines of spirofuropyridines useful in therapy
05/21/2003EP1129096B1 Crf receptor antagonists and methods relating thereto
05/21/2003EP0923581B1 4-substituted beta-carbolines as immunomodulators
05/21/2003CN1419556A Pyrano [2,3-C] imidazo[-1,2-A] pyridine convenant au traitement de troubles gastrointestinal disorders
05/21/2003CN1419554A Process for preparing crystalline form 1 of cabergoline
05/21/2003CN1419545A 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
05/21/2003CN1418879A Process for preparing 8-methoxy-quinolone
05/21/2003CN1109030C Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides
05/20/2003US6566523 Reacting mixtures of enantiomers with (-)-2,3:4,6-di-O-isopropylidene-2-keto-L-gulonic acid (or its hydrates) to form salts
05/20/2003US6566509 Compound for use as bactericide
05/20/2003US6566387 For therapy of psoriasis, atopic dermatitis, arthritis, asthma, chronic obstructive pulmonary disease, adult respiratory distress syndrome, inflammatory bowel disease, Crohn's disease, ulcerative colitis, stroke, septic shock
05/20/2003US6566364 Linear or cyclic ureas
05/20/2003US6566362 Use as topical antibiotics
05/20/2003US6566355 Useful in combination with beta -lactam antibiotics in the control of beta -lactamase forming pathogens
05/20/2003US6566086 Diagnostic kit for detecting creatine levels
05/20/2003CA2289219C 1-substituted, 2-substituted 1h-imidazo[4,5-c]quinolin-4-amines
05/20/2003CA2281244C Process for preparing trovafloxacin acid salts
05/20/2003CA2223016C Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of her-2 autophosphorylation properties
05/20/2003CA2144962C 1-(2-oxo-acetyl)-piperidine-2-carboxylic acid derivatives as multi-drug-resistant cancer cell sensitizers
05/20/2003CA2123606C New substituted pyrazolylpyrazoles, processes for their preparation, as well as intermediates, and their use as herbicides
05/20/2003CA2117059C Pyrido-pyridazinone and pyridazinthione compounds
05/15/2003WO2003040395A2 Universal nucleotides for nucleic acid analysis
05/15/2003WO2003040147A1 Azabicyclic-substituted-heteroaryl compounds for the treatment of disease__________________________________________________________________________________________________________________________
05/15/2003WO2003040143A1 Amine salts of an integrin receptor antagonist
05/15/2003WO2003040108A1 Quinazoline derivatives as antitumor agents
05/15/2003WO2003040106A1 Preparation and use of substituted imidazoles
05/15/2003WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003WO2003039552A1 Combination of pde4 or pde3/4 inhibitor and an anti-rheumatic drug
05/15/2003WO2003039549A2 Selective antibacterial agents
05/15/2003WO2003039545A2 Carboline derivatives as inhibitors of ikb in the treatment of multiple myeloma and others cancers
05/15/2003WO2003039544A1 Naphtyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors
05/15/2003WO2003039529A1 Selective antibacterial agents
05/15/2003WO2003039528A1 Pharmaceutical composition comprising an adenosine a1/a2 agonist and a sodium hydrogen exchanger inhibitor
05/15/2003WO2003039460A2 Mitotic kinesin inhibitors
05/15/2003WO2003039258A1 Pesticidal and parasitical di-and trifluorosubstituted alkene compounds
05/15/2003WO2003031435A8 Pyrazole derivatives as glycine transporter inhibitors
05/15/2003WO2003000692A3 Oxytocin agonists
05/15/2003WO2002040480A3 Crf receptor antagonists and methods relating thereto
05/15/2003WO2002000629A9 Iminopyrimidine nmda nr2b receptor antagonists
05/15/2003WO2001079173A3 Enamine derivatives as cell adhesion molecules
05/15/2003US20030092917 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as portein kinase inhibitors
05/15/2003US20030092912 Brain disorders, anticonvulsants, antidepressants, drug abruse
05/15/2003US20030092908 Autoimmune diseases; rheumatic diseases; multiple sclerosis; inflammatory bowel disease; immunosuppressants
05/15/2003US20030092732 Eating disorders; dietetics; antiinflammatory agents; autoimmune diseases
05/15/2003US20030092727 Hydroxamic and carboxylic acid derivatives
05/15/2003US20030092721 Antiinflammatory agents; rheumatic diseases
05/15/2003US20030092720 Drug efflux pump inhibitor
05/15/2003US20030092715 Aryl and biaryl compounds having MCH modulatory activity
05/15/2003US20030092712 Antiinflammatory agents; rheumatic diseases
05/15/2003US20030092706 Mixtures of phosphodiesterase inhibitor and antiarthritic agents; bioavailability, side effect reduction
05/15/2003US20030092700 Benzazepine derivatives, medicaments containing the same and their use to prepare medicaments
05/15/2003US20030092699 Imidazopyridine compounds as 5-HT4 receptor modulators
05/15/2003US20030092698 N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor Xa
05/15/2003US20030091861 Compounds with both charge transporting function and the luminescent function
05/15/2003CA2466375A1 Azabicyclic-substituted-heteroaryl compounds for the treatment of disease
05/15/2003CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003CA2465491A1 Mitotic kinesin inhibitors
05/15/2003CA2465416A1 Amine salts of an integrin receptor antagonist
05/15/2003CA2465364A1 Pharmaceutical composition comprising an adenosine a1/a2 agonist and a sodium hydrogen exchanger inhibitor
05/15/2003CA2465068A1 Quinazoline derivatives as antitumor agents
05/15/2003CA2464757A1 Selective antibacterial agents
05/14/2003EP1310498A2 Pyrazoloquinolinone derivatives as protein kinase C inhibitors
05/14/2003EP1310485A1 Pyrrole derivatives
05/14/2003EP1309594A1 Benzimidazole derivatives, preparation and therapeutic use thereof
05/14/2003EP1309593A2 Substituted pyrazoles
05/14/2003EP1309592A2 Substituted pyrazoles
05/14/2003EP1309591A2 Substituted pyrazoles
05/14/2003EP1309590A1 Azaindole derivatives, process for their preparation, and their use as antitumor agents
05/14/2003EP1309589A2 Urea compounds and methods of uses
05/14/2003EP1309565A1 Heterocyclic mutilin esters and their use as antibacterials
05/14/2003EP1309325A1 Anticonvulsant derivatives useful for the treatment of depression
05/14/2003EP1200434B1 NEW CYTOTOXIC PYRIDO 2,3,4-kl]ACRIDINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
05/14/2003EP1180105B1 Substituted aza-oxindole derivatives
05/14/2003EP1140935B1 1,2-annelated quinoline derivatives
05/14/2003EP1068208B1 Azatricyclo[3.3.1.1] decane derivatives and pharmaceutical compositions containing them
05/14/2003EP1048651B1 Nitrogen-containing tetracyclic compounds
05/14/2003EP1042317B1 Indole derivatives as PKC-inhiboitors
05/14/2003EP1029863B1 Camptothecin derivatives
05/14/2003EP0946550A4 PREPARATION OF 1S- 1a,2b,3b,4a(S*)]]-4- 7- 1-(3-CHLORO-2-THIENYL) METHYL]PROPYL]AMINO]-3H-IMIDAZO 4,5-b]PYRIDIN-3-yl]-N-ETHYL-2,3-DIHYDROXYCYCLOPENTANECARBOXAMIDE
05/14/2003EP0915869B1 Novel tricyclic n-cyanoimines useful as inhibitors of farnesyl-protein transferase
05/14/2003EP0846117B1 Process for preparation of biphenyl derivatives
05/14/2003CN1418215A Substituted beta-carbolines with IKB-kinase inhibiting activity
05/14/2003CN1418214A 4-Hydroxy-1, 8-Naphthyridine-3-carboxamides as antiviral agents
05/14/2003CN1418195A Therapeutic morpholino-substituted compounds
05/14/2003CN1418194A Amide compounds and use thereof
05/14/2003CN1418099A Choice compound for treatment of fibromyalgia and chronic fatigue syndrome
05/14/2003CN1108294C Piperazine-2,5-dione derivatives as modulators of multidrug resistance
05/13/2003US6562978 N-(3-(4-(4-(Aminocarbonyl)benzyl)-1-piperidinyl)propyl)-N-(3, 4-dichlorophenyl)-1-(methylsulfonyl)-4-piperidinecarboxamide or a salt thereof for treatment of AIDS
05/13/2003US6562975 Zolpidem is a known sedative which has the following structure:Reaction with elemental bromine in an organic diluent at a temperature of 30 to 50 degrees C., washing with water, separation, concentration and evaporation
05/13/2003US6562854 Compositions comprising a substituted benzimidazole useful for treating immunomediated inflammatory disorders
05/13/2003US6562849 Amine compound or pharmacologically acceptable salt thereof. These compounds are useful in the treatment and/or prophylaxis of diseases such as diabetes, hyperlipemia, arteriosclerosis, cancer, etc.
05/13/2003US6562822 Heterocyle carboxamides as antiviral agents
05/13/2003US6562818 Irreversible inhibitors of tyrosine kinases
05/13/2003US6562813 Aralkyl and aralkylidene heterocyclic lactams and imides
1 ... 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 ... 646